Brief: Charles Steve Theofilos Files To Report Stake Of 9.99% In Akari Therapeutics PLC As Of May 31, 2024 - SEC Filing

Akari Therapeutics

18/06/2024 22:03

Akari Therapeutics PLC  AKTX.O :
    * CHARLES STEVE THEOFILOS FILES TO REPORT STAKE OF 9.99% IN
AKARI
THERAPEUTICS PLC AS OF MAY 31, 2024  - SEC FILING

Source text for Eikon:  ID:n0000908834-24-000173 
Further company coverage:  AKTX.O